9 Frequently Asked Questions About Pharmaceutical Brand Protection

Counterfeiting and diversion threaten brands around the world, amounting to nearly half a trillion dollars a year in trade, according to a 2016 study by the Organisation for Economic Co-operation and Development and the European Union’s Intellectual Property Office.
The United States is hit the hardest by such illegal trade, per the report, and pharmaceutical products are among those at risk.
To help you decide what steps you should take for your brand, we answer some of the most common questions about brand protection in this white paper, 9 Frequently Asked Questions About Pharmaceutical Brand Protection.  
 
 
9FrequentlyAskedQuestionsCover

 

Sign up to receive the white paper, 9 Frequently Asked Questions About Pharmaceutical Brand Protection